Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of The Cervista HPV A9 group In Screening Patients for Cervical Cancer.

Journal of medical screening - 1 Mar 2016

Zhao Jinghui, Du Hui, Belinson Jerome L, Qu Xinfeng, Zhang Wei, Mei Jing, Yang Bin, Wang Chun, Zhang Lijie, Wu Ruifang

Abstract excerpt

OBJECTIVE: To exploit the prevalence of HPV genotypes 52/58 in a Chinese population, we evaluated algorithms that the use the Cervista Assay A9 group for primary cervical cancer screening. METHODS: The SHENCCAST II trial database was re-analyzed, focussing on the A9 pool of the Cervista HR-HPV Assay. Results for the detection CIN2+ and CIN3+ were correlated with a genotyping assay (MALDI-TOF) and cervical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colposcopy
Share to Early Detection of Cancer

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Multiplex Polymerase Chain Reaction

Share to Papanicolaou Test

Share to Referral and Consultation

Share to Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Share to Uterine Cervical Dysplasia

Share to Vaginal Smears

Source

Identifiers

PMID: 26466824
DOI: 10.1177/0969141315604863

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Evaluation of The Cervista HPV A9 group In Screening Patients for Cervical Cancer.PMID 26466824Read ↗

[Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].Semantic proximity Read ↗

The value of HPV genotypes combined with clinical indicators in the classification of cervical squamous cell carcinoma and adenocarcinoma.Semantic proximity Read ↗

NOVAprep-miR-Cervix: New Method for Evaluation of Cervical Dysplasia Severity Based on Analysis of Six miRNAsSemantic proximity Read ↗

Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology.Semantic proximity Read ↗

HPV16/18 Genotyping Combined with PAX1 Methylation Triage Reduces Unnecessary Colposcopy While Improving CIN3+ Detection: A Real-World Study of 3,253 Chinese WomenSemantic proximity Read ↗

The effectiveness of HPV viral load, reflected by Cobas 4800 HPV-Ct values for the triage of HPV-positive women in primary cervical cancer screening: Direct endocervical samples.Semantic proximity Read ↗

[Performance of vaginal self-sampling high-risk HPV genotyping as primary and combining cytology or viral load as secondary in cervical cancer screening].Semantic proximity Read ↗

Comparative evaluation of Allplex HPV28 and Anyplex II HPV28 assays for high-risk HPV genotyping in cervical samples.Semantic proximity Read ↗

HPV16/18 Genotyping Combined With PAX1 Methylation Triage Reduces Immediate Colposcopy While Improving CIN3+ Detection: A Real-World Study of 3,233 Chinese Women.Semantic proximity Read ↗

Evaluation and Optimization of the Clinical Accuracy of Hybribio's 14 High-Risk HPV with 16/18 Genotyping Assay within the VALGENT-3 Framework.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.